In controlled trials, subjects treated with GLP1-S displayed lower glucose area under the curve (AUC) during standardized meal tests, pointing to coordinated effects on pancreatic, hepatic, and gastrointestinal functions
GLP-1 medications are prescription treatments requiring evaluation by a licensed clinician
PlexusDx's Precision Peptide Genetic Test can reveal your genetic predisposition to GLP-1R sensitivity, helping clarify whether dietary interventions alone may suffice for your unique physiology
Speak with your healthcare provider today to start your transformation
Zepbound (Tirzepatide) Zepbound combines GLP-1 and GIP targeting, making it an effective option for substantial weight loss
Market analysts anticipate eight or more novel GLP-1-based approvals for chronic weight management over the next four years, as the drug class extends from its metabolic origins into a broader platform for addressing diseases with underlying inflammatory and cardiometabolic components